Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Validity of noninvasive markers of methotrexate-induced hepatotoxicity: a retrospective cohort study.

Martyn-Simmons CL, Rosenberg WM, Cross R, Wong T, Smith CH, Barker JN.

Br J Dermatol. 2014 Aug;171(2):267-73. doi: 10.1111/bjd.12782. Epub 2014 Jun 18.

PMID:
24942271
2.

Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.

Maurice PD, Maddox AJ, Green CA, Tatnall F, Schofield JK, Stott DJ.

Br J Dermatol. 2005 Mar;152(3):451-8.

PMID:
15787813
3.
4.

Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis.

Chalmers RJ, Kirby B, Smith A, Burrows P, Little R, Horan M, Hextall JM, Smith CH, Klaber M, Rogers S.

Br J Dermatol. 2005 Mar;152(3):444-50.

PMID:
15787812
5.

Serum type III procollagen aminopeptide for assessing liver damage in methotrexate-treated psoriatic patients.

Boffa MJ, Smith A, Chalmers RJ, Mitchell DM, Rowan B, Warnes TW, Shomaf M, Haboubi NY.

Br J Dermatol. 1996 Oct;135(4):538-44.

PMID:
8915142
6.

The use of transient elastography and FibroTest for monitoring hepatotoxicity in patients receiving methotrexate for psoriasis.

Lynch M, Higgins E, McCormick PA, Kirby B, Nolan N, Rogers S, Lally A, Vellinga A, Omar H, Collins P.

JAMA Dermatol. 2014 Aug;150(8):856-62. doi: 10.1001/jamadermatol.2013.9336.

PMID:
24964792
7.
8.

Enhanced liver fibrosis panel as a predictor of liver fibrosis in chronic hepatitis C patients.

Fernandes FF, Ferraz ML, Andrade LE, Dellavance A, Terra C, Pereira G, Pereira JL, Campos F, Figueiredo F, Perez RM.

J Clin Gastroenterol. 2015 Mar;49(3):235-41. doi: 10.1097/MCG.0000000000000128.

PMID:
24714186
9.

Diagnostic accuracy of noninvasive markers of liver fibrosis in patients with psoriasis taking methotrexate: a systematic review and meta-analysis.

Maybury CM, Samarasekera E, Douiri A, Barker JN, Smith CH.

Br J Dermatol. 2014 Jun;170(6):1237-47. doi: 10.1111/bjd.12905. Review.

PMID:
24588075
10.

The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.

Lichtinghagen R, Pietsch D, Bantel H, Manns MP, Brand K, Bahr MJ.

J Hepatol. 2013 Aug;59(2):236-42. doi: 10.1016/j.jhep.2013.03.016. Epub 2013 Mar 21. Erratum in: J Hepatol. 2013 Dec;59(6):1365.

PMID:
23523583
11.

The value of dynamic hepatic scintigraphy and serum aminoterminal propeptide of type III procollagen for early detection of methotrexate-induced hepatic damage in psoriasis patients.

vanDooren-Greebe RJ, Kuijpers AL, Buijs WC, Kniest PH, Corstens FH, Nagengast FM, de Boo T, Willems JL, Duller P, van de Kerkhof PC.

Br J Dermatol. 1996 Mar;134(3):481-7.

PMID:
8731673
12.

Use of amino terminal type III procollagen peptide (P3NP) assay in methotrexate therapy for psoriasis.

Khan S, Subedi D, Chowdhury MM.

Postgrad Med J. 2006 May;82(967):353-4. Erratum in: Postgrad Med J. 2006 Aug;82(970):482.

13.

Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis and arthritis.

Zachariae H, Aslam HM, Bjerring P, Søgaard H, Zachariae E, Heickendorff L.

J Am Acad Dermatol. 1991 Jul;25(1 Pt 1):50-3.

PMID:
1880254
14.

Biomarkers for methotrexate-induced liver injury: urinary protein profiling of psoriasis patients.

van Swelm RP, Laarakkers CM, Kooijmans-Otero M, de Jong EM, Masereeuw R, Russel FG.

Toxicol Lett. 2013 Aug 29;221(3):219-24. doi: 10.1016/j.toxlet.2013.06.234. Epub 2013 Jul 3.

PMID:
23830989
15.

Assessment and management of methotrexate hepatotoxicity in psoriasis patients: report from a consensus conference to evaluate current practice and identify key questions toward optimizing methotrexate use in the clinic.

Barker J, Horn EJ, Lebwohl M, Warren RB, Nast A, Rosenberg W, Smith C; International Psoriasis Council.

J Eur Acad Dermatol Venereol. 2011 Jul;25(7):758-64. doi: 10.1111/j.1468-3083.2010.03932.x. Epub 2010 Dec 29. Review.

PMID:
21198946
16.

Diagnostic performance of transient elastography for detection of methotrexate-induced liver injury using Roenigk classification in Asian patients with psoriasis: a retrospective study.

Rongngern P, Chularojanamontri L, Wongpraparut C, Silpa-Archa N, Chotiyaputta W, Pongpaibul A, Charatcharoenwitthaya P.

Arch Dermatol Res. 2017 Jul;309(5):403-408. doi: 10.1007/s00403-017-1733-4. Epub 2017 Mar 16.

PMID:
28303329
17.
18.
19.

Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.

Lindsay K, Fraser AD, Layton A, Goodfield M, Gruss H, Gough A.

Rheumatology (Oxford). 2009 May;48(5):569-72. doi: 10.1093/rheumatology/kep023. Epub 2009 Mar 9.

PMID:
19273538
20.

[Serum liver tests in patients treated with methotrexate. A retrospective analysis].

Correa G H, Paredes S N.

Rev Med Chil. 2007 Aug;135(8):1002-8. Epub 2007 Oct 25. Spanish.

Supplemental Content

Support Center